Aquestive Therapeutics (AQST) Receivables (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Receivables of $8.5 million for Q1 2026, down 33.06% year-over-year from $12.7 million in Q1 2025, and down 69.21% quarter-over-quarter from $27.5 million in Q4 2025.
Aquestive Therapeutics (AQST) Receivables (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Receivables history runs 10 years deep, the most recent figure standing at $8.5 million for Q1 2026.
- In Q1 2026, Receivables fell 33.06% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (down 33.06% YoY), while the FY2025 annual figure was $27.5 million, up 180.26% from the prior year.
- Receivables for Q1 2026 stood at $8.5 million, down from $27.5 million in the prior quarter.
- The five-year high for Receivables was $27.5 million in Q4 2025, with the low at $6.8 million in Q4 2022.
- The 5-year median for Receivables is $11.7 million (2024), against an average of $13.2 million.
- The sharpest annual moves came in 2022 and 2025: Receivables plunged 55.0% in 2022, then jumped 180.26% in 2025.
- Aquestive Therapeutics' Receivables stood at $6.8 million in 2022, then jumped by 66.39% to $11.4 million in 2023, then retreated by 13.78% to $9.8 million in 2024, then surged by 180.26% to $27.5 million in 2025, then slumped by 69.21% to $8.5 million in 2026.
- Business Quant data shows AQST's Receivables at $8.5 million in Q1 2026, $27.5 million in Q4 2025, and $14.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Aquestive Therapeutics | 554.85 Mn | 554.85 Mn | 9.80 Mn | 10.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.93 Mn |
| Mar 31, 2026 | 8.47 Mn |
| Dec 31, 2025 | 27.51 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Jun 30, 2025 | 14.07 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 9.82 Mn |
| Sep 30, 2024 | 11.68 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | 11.39 Mn |
| Sep 30, 2023 | 10.29 Mn |
| Jun 30, 2023 | 12.27 Mn |
| Mar 31, 2023 | 11.06 Mn |
| Dec 31, 2022 | 6.84 Mn |
| Sep 30, 2022 | 12.89 Mn |
| Jun 30, 2022 | 22.64 Mn |
| Mar 31, 2022 | 21.72 Mn |
| Dec 31, 2021 | 15.21 Mn |
| Sep 30, 2021 | 16.28 Mn |